Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

被引：0
作者：
Lorenzo Catanese
Katharina Link
Harald Rupprecht
机构：
[1] Klinikum Bayreuth GmbH,Department of Medicine V (Nephrology, Hypertensiology, Angiology and Rheumatology)
[2] Medizincampus Oberfranken,undefined
[3] Friedrich-Alexander-University Erlangen-Nürnberg,undefined
[4] Kuratorium for Dialysis Bayreuth,undefined
来源：
BMC Nephrology | / 24卷
关键词：
Case report; Thrombotic microangiopathy (TMA); Multiple myeloma (MM); Carfilzomib; Eculizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 109 条
[1]  
Moreau P(2015)Frontline therapy of multiple myeloma Blood 125 3076-3084
[2]  
Attal M(2016)Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group Mayo Clin Proc 91 1189-1211
[3]  
Facon T(2021)Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management J Clin Med 10 536-547
[4]  
Go RS(2018)Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura Hematol Am Soc Hematol Educ Program 2018 539-148
[5]  
Winters JL(2017)Haemolytic uraemic syndrome J Intern Med 281 123-21
[6]  
Leung N(2019)Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment: Update on Atypical Hemolytic Uremic Syndrome Ther Apher Dial 23 4-1316
[7]  
Murray DL(2009)Complement inhibitor eculizumab in atypical hemolytic uremic syndrome Clin J Am Soc Nephrol 4 1312-e164
[8]  
Willrich MA(2019)A review of thrombotic microangiopathies in multiple myeloma Leuk Res 85 e157-2685
[9]  
Abraham RS(2017)Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study Lancet Haematol 4 2673-42
[10]  
Sukumar S(2012)Thrombotic microangiopathy and associated renal disorders Nephrol Dial Transplant 27 31-59
12345678910